Literature DB >> 32562130

Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences.

Alessandro Bianchi1, Alberto Pagan-Pomar2, Marina Jimenez-Segovia2, José Antonio Martinez-Corcoles2, Francesc Xavier Gonzalez-Argenté2.   

Abstract

PURPOSE: In the multidisciplinary therapeutic approach to obesity, bariatric surgery is considered the most effective treatment in weight reduction and the decrease in associated comorbidities. The objective of this work is to describe the long-term clinical and metabolic results in obese patients undergoing biliopancreatic diversion (BPD) according to Scopinaro's technique.
MATERIALS AND METHODS: Patients undergoing surgery were followed by the same multidisciplinary team in a study period of 15 years (1999-2015). A retrospective study based on a prospective database was designed, where data on the evolution of obesity-related diseases and nutritional parameters were studied.
RESULTS: Two hundred seventy-seven patients were collected; 75.5% were women. The preoperative body mass index (BMI) decreased from 52.5 kg/m2 to 34.9 kg/m2 10 years after surgery. A resolution or improvement of diabetes has been observed in 85.38% of the patients; a decrease in arterial hypertension and obstructive sleep apnea syndrome were in 65.61% and 89.14%, respectively. Throughout the monitoring of the sample, protein malnutrition increased, from 1.8% after the first year of surgery to 4.5% 10 years after the operation.
CONCLUSION: Even if Scopinaro's technique is beginning to be replaced by other malabsorptive techniques, it can still be considered as an effective surgical procedure in terms of weight loss, quality of life, and evolution of obesity-related diseases. In order to avoid nutritional deficiencies, the operated patients need a strict follow-up and a supplementation adjusted to the technique.

Entities:  

Keywords:  Bariatric surgery,; Biliopancreatic diversion,; Long-term,; Nutritional complications; Severe obesity,

Mesh:

Year:  2020        PMID: 32562130     DOI: 10.1007/s11695-020-04777-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  38 in total

1.  Obesity surgery results depending on technique performed: long-term outcome.

Authors:  J A Gracia; M Martínez; M Elia; V Aguilella; P Royo; A Jiménez; M A Bielsa; D Arribas
Journal:  Obes Surg       Date:  2008-11-12       Impact factor: 4.129

2.  Five-year follow-up after biliopancreatic diversion with duodenal switch.

Authors:  Philippe Topart; Guillaume Becouarn; Agnès Salle
Journal:  Surg Obes Relat Dis       Date:  2010-11-13       Impact factor: 4.734

Review 3.  Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: a Practical Guideline.

Authors:  Mastaneh Rajabian Tabesh; Faezeh Maleklou; Fatemeh Ejtehadi; Zahra Alizadeh
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

Review 4.  For whom the bell tolls? It is time to retire the classic BPD (bilio-pancreatic diversion) operation.

Authors:  Michel Gagner
Journal:  Surg Obes Relat Dis       Date:  2019-03-23       Impact factor: 4.734

5.  Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity.

Authors:  Albert Lecube; Susana Monereo; Miguel Ángel Rubio; Purificación Martínez-de-Icaya; Amelia Martí; Javier Salvador; Lluís Masmiquel; Alberto Goday; Diego Bellido; Empar Lurbe; José Manuel García-Almeida; Francisco José Tinahones; Pedro Pablo García-Luna; Enrique Palacio; Manuel Gargallo; Irene Bretón; Salvador Morales-Conde; Assumpta Caixàs; Edelmiro Menéndez; Manel Puig-Domingo; Felipe F Casanueva
Journal:  Endocrinol Diabetes Nutr       Date:  2016-08-16

6.  Bilio-pancreatic bypass for obesity: II. Initial experience in man.

Authors:  N Scopinaro; E Gianetta; D Civalleri; U Bonalumi; V Bachi
Journal:  Br J Surg       Date:  1979-09       Impact factor: 6.939

Review 7.  Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

Authors:  Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge
Journal:  Am J Med       Date:  2009-03       Impact factor: 4.965

8.  Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)).

Authors:  George Skroubis; Natasa Kouri; Nancy Mead; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 9.  Metabolic Surgery as a Treatment Option for Type 2 Diabetes Mellitus: Surgical View.

Authors:  Eric Rachlin; Carlos Galvani
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

Review 10.  CRITICAL ANALYSIS OF SURGICAL TREATMENT TECHNIQUES OF MORBID OBESITY.

Authors:  Bruno Zilberstein; Marco Aurélio Santo; Marnay Helbo Carvalho
Journal:  Arq Bras Cir Dig       Date:  2019-10-21
View more
  1 in total

1.  Evaluating the Pharmacoeconomic Impact of Nutrient Supplementation Post-operatively on Patients Receiving Roux-Y Gastric Bypass vs. Biliopancreatic Diversion with Duodenal Switch.

Authors:  Fiona A van Vollenstee; Maria T van der Merwe
Journal:  Obes Surg       Date:  2021-03-17       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.